
    
      PROTOCOL OUTLINE: Patients receive IV or oral busulfan every 6 hours on days -9 to -6;
      cyclophosphamide IV on days -5 to -2; anti-thymocyte globulin IV on days -4 to -2; and
      allogeneic bone marrow transplantation (BMT) on day 0.

      Patients with class 3 thalassemia (liver edge greater than 2 cm below costal margin, a
      history of inconsistent chelation, and portal fibrosis) receive a less intensive conditioning
      regimen consisting of oral busulfan every 6 hours on days -7 to -4; anti-thymocyte globulin
      IV on days -5 to -1 and days 1-5; cyclophosphamide IV on days -3 to -2; and allogeneic BMT on
      day 0.

      Patients are followed at day 28, and then at 3, 6, 12, and 24 months.
    
  